RF ablation 'biopsy' shows prognostic potential

Article

The histopathology of residual tissue from radiofrequency ablation probes after ablation of hepatocellular carcinomas could predict local tumor progression independently from other tests, according to a study presented at the 2007 Society of Interventional Radiology meeting.

The histopathology of residual tissue from radiofrequency ablation probes after ablation of hepatocellular carcinomas could predict local tumor progression independently from other tests, according to a study presented at the 2007 Society of Interventional Radiology meeting.

Dr. Constantinos T. Sofocleous, an interventional radiologist at Memorial Sloan-Kettering Cancer Center in New York City, and colleagues prospectively classified 55 specimens harvested from RFA probes after liver treatment as coagulation necrosis and 13 as viable tumors. They found that these tissue samples could predict when RFA treatment would not be successful. Primary local tumor progression occurred in 92% of viable tumors versus 29% of those identified by post-RFA biopsy as necrotic. Investigators also found the long-term progression-free interval was about six times greater in the necrotic group. Both findings were statistically significant (p < 0.001).

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
CT-Based Deep Learning Model May Reduce False Positives with Indeterminate Lung Nodules by Nearly 40 Percent
Leading Breast Radiologists Discuss Rise of Breast Cancer Incidence in Women Under 40
New Research Examines Radiation Risks with CT Exposure Prior to Pregnancy
© 2025 MJH Life Sciences

All rights reserved.